Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus

Journal of Pharmacology and Experimental Therapeutics

Volumn 340, Issue 1, 2012, Pages 73-82

  Starr, M A ^a   Page, M E ^a   Waterhouse, B D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; ELECTRODE; EVOKED SOMATOSENSORY RESPONSE; IMPLANTATION; MALE; MECHANICAL STIMULATION; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; PIEZOELECTRICITY; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; SEROTONIN RELEASE; SINGLE DRUG DOSE; SOMATOSENSORY SYSTEM; SPIKE WAVE; THALAMUS; TRIGEMINAL SOMATOSENSORY SYSTEM; VENTRAL POSTERIOR MEDIAL THALAMUS; VIBRISSA;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHYSIOLOGICAL PHENOMENA; EVOKED POTENTIALS, SOMATOSENSORY; EXCITATORY POSTSYNAPTIC POTENTIALS; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PATCH-CLAMP TECHNIQUES; PHYSICAL STIMULATION; POSTERIOR THALAMIC NUCLEI; RATS; RATS, LONG-EVANS; SEROTONIN; SEROTONIN AGENTS; VIBRISSAE;

EID: 84055213511     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.185728     Document Type: Article

References (31)

1. Abercrombie ED, Keller RW Jr, and Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 27:897-904. (Pubitemid 19025396)
2. Armstrong-James M and Fox K (1987) Spatiotemporal convergence and divergence in the rat S1 "barrel" cortex. J Comp Neurol 263:265-281. (Pubitemid 17128684)
3. Baumann MH, Clark RD, Franken FH, Rutter JJ, and Rothman RB (2008) Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience 152:773-784.
4. Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, and Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37:2163-2170.
5. Beitia G, Cobreros A, Sainz L, and Cenarruzabeitia E (2000) Ecstasy-induced toxicity in rat liver. Liver 20:8-15. (Pubitemid 30095283)
6. Cadoni C, Solinas M, and Di Chiara G (2000) Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol 388:69-76. (Pubitemid 30066438)
7. Callaway CW and Geyer MA (1992) Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine 1B agonist. J Pharmacol Exp Ther 263:318-326.
8. Cerretani D, Bello S, Cantatore S, Fiaschi AI, Montefrancesco G, Neri M, Pomara C, Riezzo I, Fiore C, Bonsignore A, Turillazzi E, and Fineschi V (2011) Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver. Pharmacol Res 64:517-527.
9. Chapin JK, Waterhouse BD, and Woodward DJ (1981) Differences in cutaneous sensory response properties of single somatosensory cortical neurons in awake and halothane anesthetized rats. Brain Res Bull 6:63-70. (Pubitemid 11129584)
10. de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, and Camí J (2000) Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 49:104-109.
11. Fantegrossi WE (2008) In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys. Exp Clin Psychopharmacol 16:1-12.
12. Ferrara SD, Zancaner S, and Giorgetti R (1994) Low blood alcohol concentrations and driving impairment. A review of experimental studies and international legislation. Int J Legal Med 106:169-177. (Pubitemid 24113844)
13. Flemen K (1997) Smoke and Whispers: Drugs and Youth Homelessness in Central London, p 64, Hungerford Drug Project, London.
14. Frederick DL, Ali SF, Slikker W Jr, Gillam MP, Allen RR, and Paule MG (1995) Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neurotoxicol Teratol 17:531-543.
15. Greer G and Tolbert R (1986) Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 18:319-327. (Pubitemid 17231263)
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
17. Kalivas PW, Duffy P, and White SR (1998) MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18:469-479. (Pubitemid 28202354)
18. Kirifides ML, Simpson KL, Lin RC, and Waterhouse BD (2001) Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat. J Comp Neurol 435:325-340. (Pubitemid 32523649)
19. Marston HM, Reid ME, Lawrence JA, Olverman HJ, and Butcher SP (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology 144:67-76. (Pubitemid 29242672)
20. Moon KH, Upreti VV, Yu LR, Lee IJ, Ye X, Eddington ND, Veenstra TD, and Song BJ (2008) Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics 8:3906-3918.
21. Mueller M, Peters FT, Maurer HH, McCann UD, and Ricaurte GA (2008) Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. J Pharmacol Exp Ther 327:38-44.
22. Ogden EJ and Moskowitz H (2004) Effects of alcohol and other drugs on driver performance. Traffic Inj Prev 5:185-198. (Pubitemid 39049922)
23. Parrott AC (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol 19:71-83.
24. Pierce RC and Kalivas PW (1998) Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 17:3254-3261.
25. Pizarro N, Ortuño J, Farré M, Hernández-López C, Pujadas M, Llebaria A, Joglar J, Roset PN, Mas M, Segura J, et al. (2002) Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26:157-165. (Pubitemid 34309726)
26. Reveron ME, Maier EY, and Duvauchelle CL (2010) Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration. Behav Brain Res 207:500-507.
27. Simpson KL, Altman DW, Wang L, Kirifides ML, Lin RC, and Waterhouse BD (1997) Lateralization and functional organization of the locus coeruleus projection to the trigeminal somatosensory pathway in rat. J Comp Neurol 385:135-147. (Pubitemid 27329823)
28. Starr MA, Page ME, and Waterhouse BD (2008) MDMA (3,4- methylenedioxymethamphetamine)- mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posterior medial thalamus. J Pharmacol Exp Ther 327:20-31.
29. Waterhouse BD, Azizi SA, Burne RA, and Woodward DJ (1990) Modulation of rat cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis. Brain Res 514:276-292. (Pubitemid 20151378)
30. Waterhouse BD, Moises HC, and Woodward DJ (1986) Interaction of serotonin with somatosensory cortical neuronal responses to afferent synaptic inputs and putative neurotransmitters. Brain Res Bull 17:507-518. (Pubitemid 16010377)
31. Waterhouse BD and Woodward DJ (1980) Interaction of norepinephrine with cerebrocortical activity evoked by stimulation of somatosensory afferent pathways in the rat. Exp Neurol 67:11-34. (Pubitemid 10172194)